Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Intermediate Control
(rac)-Dihydrophytol is a versatile intermediate involved in the biosynthesis of Phytanic acid. It is utilized in research applications focused on the metabolic pathways of branched-chain fatty acids. This compound serves as a valuable tool in studies investigating lipid metabolism and related disorders. -
Drug Intermediate
3-((1-Carboxy-2-((5,5-dimethyl-4,5-dihydroisoxazol-3-yl)thio)ethyl)amino)-3-oxopropanoic acid serves as a crucial organic synthetic intermediate in chemical research. Its molecular structure is designed to facilitate the synthesis of novel compounds with potential therapeutic applications. This reagent is particularly useful in the development of pharmacologically active molecules, contributing to advancements in medicinal chemistry. -
Drug Intermediate
(1R,3S)-3-Hydroxycyclopentane acetic acid is a drug intermediate that plays a critical role in the synthesis of various pharmaceutical compounds. Its unique structure aids in the modification of drug activities, making it valuable for medicinal chemistry research. This compound is utilized in the development of novel therapeutics and contributes to the advancement of drug discovery processes. -
Drug Intermediate
tert-Butyl p-Toluate, also known as tert-Butyl p-methylbenzoate, functions as a synthetic intermediate in the pharmaceutical synthesis process. This compound serves a crucial role in the development of various chemical entities, facilitating the formation of complex molecules in drug discovery and development. Its utility in organic synthesis makes it a valuable reagent for researchers focused on medicinal chemistry and related fields. -
Drug Intermediate
3-Dimethylaminooxalyl-4-acetylindole serves as an important intermediate in the synthesis of Psilocin and Psilocybin, two significant compounds in psychedelic research. This reagent enables the preparation of these psychoactive substances, facilitating studies on their biological effects and therapeutic potential. Its role as a synthetic precursor is vital for advancing research within the fields of pharmacology and neurobiology. -
Drug Intermediate
Caspofungin impurity A is a byproduct formed during the synthesis of Caspofungin, a potent antifungal agent targeting β-(1,3)-D-glucan in the fungal cell wall. This impurity serves as a valuable drug intermediate for research and analysis in antifungal drug development. Its study aids in understanding the synthesis process and the characterization of related compounds within the context of pharmaceutical applications. -
Drug Intermediate
Ticagrelor acetonide, also known as Isopropylidene ticagrelor, serves as a key drug intermediate in the synthesis of lysine-specific demethylase (LSD1) inhibitors. This compound is instrumental in advancing research focused on epigenetic regulation and its implications in various diseases. Its role in the development of novel therapeutic agents highlights its significance in chemical biology and pharmacological studies. -
Drug Intermediate
3,2'-Dihydroxyflavone is a flavonol compound primarily utilized as a drug intermediate in the synthesis of tetracyclic compounds. It exhibits notable biological activity, making it a valuable reagent in pharmaceutical research. Its structural characteristics allow for further modifications, contributing to the development of novel therapeutic agents. -
Drug Intermediate Control
4-(2-Acetoxyacetyl)phenyl acetate is a synthetic intermediate primarily utilized in the synthesis of phenethylamine metabolites. This compound serves as a valuable tool in drug development and medicinal chemistry research, facilitating the exploration and production of various therapeutic agents. Its role in synthetic routes enhances the efficiency of creating diverse chemical structures for biological applications. -
Drug Intermediate
N1,N4-Di-P-tolylbenzene-1,4-diamine is an important chemical intermediate widely utilized in organic synthesis. This compound serves as a catalyst, enhancing the efficiency of various reactions and promoting the formation of targeted molecular structures. Its unique properties make it valuable for research applications in drug discovery and development, as it aids in the synthesis of complex pharmaceutical compounds. -
Drug Intermediate Control
5-Dibromomethyl anastrozole is a synthetic intermediate utilized in the production of the aromatase inhibitor Anastrozole (CYP19A1). This compound plays a critical role in the synthesis pathway, aiding in the development of therapies targeting estrogen receptor-positive breast cancer. Its biological activity contributes to the effective modulation of estrogen levels for research into related oncological applications. -
Drug Intermediate
Dehydrocyclopeptine serves as a critical intermediate in the synthesis of benzodiazepine alkaloids derived from the Penicillium species. This compound plays a pivotal role in the formation of various pharmacologically active substances, facilitating research into neuroactive agents and potential therapeutic applications. Its significance in the study of natural product synthesis makes it a valuable reagent for researchers in medicinal chemistry and pharmaceutical development. -
Drug Intermediate
p-SCN-Bn-DOTA(tBu)4 is a derivative of DOTA that acts as a drug intermediate. It serves as a key component in the Gd(III)-DOTA-IAC, a targeted magnetic resonance imaging (MRI) contrast agent designed for the αvβ3 integrin receptor. This compound is valuable in biomedical research for developing specific imaging agents that can enhance the visualization of tumor tissues and facilitate targeted therapies. -
Drug Intermediate
Levetiracetam impurity 9 is identified as a drug intermediate in the synthesis of Levetiracetam. This chemical is primarily utilized for the characterization and quality control of Levetiracetam formulations. Its presence serves as a reference standard in analytical assays and helps ensure the purity of pharmaceutical products. -
Drug Intermediate
(2R,3S)-3-Isopropylmalic acid is a key intermediate in the biosynthetic pathway of leucine. It acts as the primary endogenous substrate for the Saccharomyces cerevisiae Tmt1 methyltransferase, playing a vital role in essential metabolic processes. This compound is important for research applications focused on amino acid biosynthesis and metabolic regulation. -
Drug Intermediate
3-Pyridylamide oxime serves as a synthetic intermediate in pharmaceutical synthesis, facilitating the development of various bioactive compounds. It is primarily utilized in the preparation of pyridine-based pharmaceuticals and is valuable in medicinal chemistry for its role in drug discovery and development. Its unique chemical structure enables researchers to explore novel therapeutic agents and optimize pharmacological properties. -
Drug Intermediate
2-Methyl-1H-pyrrolo[2,3-b]pyridine serves as a valuable drug intermediate in organic synthesis, particularly in the development of complex pharmaceutical compounds. This heterocyclic organic molecule is instrumental in the construction of various targeted therapies, including BMS-645737, a potent inhibitor of VEGFR-2. Its utility in drug design underscores its significance in advancing research in medicinal chemistry and therapeutic applications. -
Drug Intermediate
4-(1-Piperazinyl)-1H-Indole hydrochloride is a synthetic intermediate primarily utilized in pharmaceutical synthesis. This compound plays a crucial role in the development of various drugs by facilitating the formation of indole-based scaffolds. Its structural attributes support research into bioactive molecules, making it valuable for medicinal chemistry applications. -
Drug Intermediate Control
Ethyl 2-(3-hydroxyphenyl)-4-methylthiazole-5-carboxylate is a synthetic intermediate that serves as an essential building block in pharmaceutical synthesis. This compound is designed for applications in drug development, facilitating the formation of various active pharmaceutical ingredients. Its versatile structural features make it a valuable reagent in medicinal chemistry and drug formulation processes. -
Drug Intermediate Control
7-Piperazin-1-yl-thieno[2,3-c]pyridine hydrochloride is a synthetic chemical compound that serves as a key intermediate in pharmaceutical synthesis. Its structure and properties make it valuable for the development of various drug candidates. This reagent is commonly utilized in chemical research to explore new therapeutic avenues and enhance the efficacy of drug formulations. -
Drug Intermediate
Nordiazepam uncyclized intermediate hydrochloride is a prodrug intermediate utilized in the synthesis of Nordiazepam. This compound plays a crucial role in the development of anxiolytic and sedative agents by modulating GABAergic activity in the central nervous system. Its applications are primarily focused on drug discovery and development within the pharmaceutical industry, particularly in the formulation of therapeutic agents for anxiety and sleep disorders. -
Drug Intermediate
DOTA-PEG4-OSu is a bifunctional conjugate that combines a chelating agent with a PEG-based linker. It serves as a crucial intermediate for synthesizing radionuclide reagents, specifically 68Ga-DOTA-PEG4-(GGG-cKiE)2. This compound is instrumental in radiopharmaceutical applications, particularly in the development of targeted imaging agents for diagnostic purposes. -
Drug Intermediate
2-(3-Pyridyl)-4-methyl-thiazole-5-carboxylic acid is a synthetic intermediate utilized in pharmaceutical synthesis. This compound serves as a building block for the development of various drug candidates, contributing to the formation of thiazole-based pharmacophores. It is applicable in medicinal chemistry for creating novel therapeutics with potential biological activity. -
Drug Intermediate Control
2-Methyl-4-phenyl thiazole is a synthetic intermediate primarily utilized in pharmaceutical synthesis. This compound serves as a crucial building block in the production of various bioactive molecules, facilitating the development of potential therapeutics. Its application spans across medicinal chemistry, where it aids in the design and optimization of new drug candidates. -
Drug Intermediate
(1S,3S)-3-Aminomethyl-cyclopentanol is a synthetic intermediate primarily utilized in pharmaceutical synthesis. Its structural framework provides a valuable scaffold for the development of various bioactive compounds, making it essential in medicinal chemistry. This reagent is applicable in research focused on the synthesis of novel therapeutics and drug discovery. -
Drug Intermediate
BOC-(1R,3S)-3-aminocyclopentane carboxylic acid is a synthetic intermediate primarily utilized in pharmaceutical synthesis. Its structural components make it valuable in the development of bioactive compounds, particularly in generating cyclic amino acids. This compound supports various research applications, including the synthesis of peptidomimetics and the exploration of drug candidates targeting specific biological pathways. -
Drug Intermediate Control
(1S,3R)-3-Aminocyclopentanol functions as a versatile synthetic intermediate in pharmaceutical development. This compound is integral for the synthesis of various biologically active molecules, contributing to the advancement of medicinal chemistry. Its chiral nature allows for the production of enantioselective compounds, making it valuable in the design of targeted therapeutics. -
Drug Intermediate
(S)-3-Oxo-cyclopentanecarboxylic acid methyl ester serves as a synthetic intermediate in pharmaceutical synthesis. It is integral in the development of various drug compounds, facilitating the creation of complex molecular architectures. This reagent is valuable for researchers focused on medicinal chemistry and the production of bioactive molecules. -
Non-steroidal Antirheumatic Agent
Lonazolac is a non-steroidal antirheumatic agent that primarily targets inflammatory pathways. It exhibits significant anti-inflammatory effects, making it useful in the study of inflammatory diseases such as rheumatoid arthritis. This compound serves as a valuable tool in research applications focused on pain management and the modulation of immune responses. -
Drug Intermediate Control
(Rac)-7-Methoxy propranolol is a key synthetic intermediate that plays a critical role in the production of pharmaceuticals. This compound is utilized in drug formulation and development, particularly in studies related to beta-adrenergic receptor antagonism, which is important for cardiovascular research. Its chemical structure facilitates various synthetic pathways in the creation of effective therapeutics. -
Drug Intermediate
Dimecrotic acid is an organic acid that functions as a valuable drug intermediate in pharmaceutical synthesis. Its chemical properties facilitate the development of various therapeutic agents, supporting research in drug discovery and development. The compound is essential for creating complex organic molecules, thereby enhancing the efficiency of synthetic pathways in medicinal chemistry. -
Drug Intermediate
2-Acetyldibenzofuran is a dibenzofuran derivative utilized as a drug intermediate. It plays a crucial role in the synthesis of photosensitizers, which are important in photodynamic therapy and other applications requiring light-sensitive compounds. Its utility in organic synthesis makes it valuable for research in medicinal chemistry and related fields. -
Drug Intermediate Control
Benzyl (1R,3R)-3-hydroxycyclopentane-1-carboxylate serves as a synthetic intermediate primarily utilized in pharmaceutical synthesis. This compound is crucial for the development of various bioactive molecules with potential therapeutic applications. Its role as an intermediate enables the structural modification of lead compounds, facilitating the discovery of novel drugs targeting diverse biological pathways. -
Drug Intermediate
(1-Benzylpiperidin-3-yl)methanol is a chemical intermediate primarily used in the synthesis of pharmaceutical compounds. This compound facilitates research into Alzheimer's disease by serving as a precursor for biologically active molecules. Its applications extend to the development of potential therapeutic agents aimed at understanding and treating neurodegenerative disorders. -
Drug Intermediate
N-Demethy EM-163 is a key intermediate in the synthesis of the compound EM-163. This reagent facilitates the production of EM-163, which is recognized for its potential therapeutic applications. Researchers utilize N-Demethy EM-163 in drug development processes, particularly in studying the pharmacological effects of EM-163 and its related derivatives. -
Drug Intermediate
2,2,6-Trimethylcyclohexanone, a versatile drug intermediate, plays a crucial role in the synthesis of β-ionone, an important compound in fragrance and flavor industries. Its structural properties make it an essential building block for various synthetic routes in organic chemistry. Researchers utilize this compound in the development of bioactive molecules and in the study of related chemical transformations. -
Drug Intermediate Control
Ethyl-2-(2-pyridyl)-4-(bromomethyl)-Thiazole-5-Carboxylate serves as a valuable synthetic intermediate in pharmaceutical synthesis. This compound exhibits potential utility in the development of novel therapeutic agents, enabling the creation of complex thiazole derivatives. Its application is essential in drug discovery processes focused on various biological targets, allowing researchers to explore new pathways in medicinal chemistry. -
Drug Intermediate
tert-Butyl 4-(1H-indol-4-yl)piperazine-1-carboxylate functions as a synthetic intermediate in pharmaceutical synthesis. This compound is valuable for the development of various bioactive molecules due to its piperazine and indole functionalities, contributing to the modulation of diverse biological targets. Its application is essential in drug discovery and development processes. -
Drug Intermediate
3-Methoxy-4-(methoxymethoxy)aniline serves as a key pharmaceutical intermediate with applications in the synthesis of histone deacetylase (HDAC) inhibitors. This compound's structure facilitates the development of various bioactive molecules, enabling the exploration of therapeutic strategies in cancer and other diseases associated with epigenetic regulation. Its role in drug discovery makes it an important reagent for researchers focused on epigenetic therapies. -
Drug Intermediate
Mesalazine impurity 7 is a drug intermediate associated with the synthesis of Mesalazine. It serves as a valuable reference standard for analytical applications such as purity assessment and method development in pharmaceutical research. Understanding impurities like Mesalazine impurity 7 is essential for ensuring the quality and safety of Mesalazine-containing formulations. -
Drug Intermediate
GS-1427 intermediate-1 is a crucial intermediate in the synthesis of the compound GS-1427. This reagent plays an essential role in the production and development of therapeutic agents targeting specific biological pathways. Its unique chemical structure supports researchers in investigating potential pharmaceutical applications within various domains of drug discovery. -
Drug Intermediate
2-Deoxy-D-ribose 1-phosphate is a key intermediate involved in the metabolism of phosphoinositides. This compound is particularly relevant in studies of cellular signaling pathways and membrane dynamics in neurological research. Its utilization can provide insights into the biochemical mechanisms that underlie various neurological processes and drug development. -
Drug Intermediate Control
(4-((Neopentyloxy)sulfonyl)phenyl)boronic acid acts as a drug intermediate control with relevance in chemical synthesis. This compound serves as a versatile building block for the production of various pharmaceuticals and research reagents, facilitating the development of novel medicinal compounds. Its unique structural properties contribute to its utility in organic synthesis applications, promoting efficiency in complex molecule assembly. -
Drug Intermediate
(S,S)-Reboxetine-OH is a phenolic compound that serves as a vital drug intermediate in pharmaceutical research. Its primary application involves the synthesis of norepinephrine transporter ligands, facilitating investigations into neurotransmitter dynamics and potential therapeutic targets for mood disorders. This compound is instrumental in the development of novel therapeutic agents that modulate norepinephrine levels in the central nervous system. -
Drug Intermediate
Fluticasone propionate O-diphosphoethanolamine serves as a key drug intermediate in the synthesis of Fluticasone. This compound is utilized in pharmaceutical research and development, particularly in the formulation of corticosteroids for anti-inflammatory therapies. Its biological activity is critical for the synthesis of effective therapeutic agents targeting respiratory diseases. -
Drug Intermediate
4-Amino benzamidoxime is a synthetic intermediate with a primary mechanism of acting as a precursor in pharmaceutical synthesis. This compound serves as a versatile building block in the development of various drug candidates, particularly in the formation of amidoximes. Its key biological activity is linked to its application in the synthesis of biologically active compounds, making it valuable for medicinal chemistry research. -
Drug Intermediate
(1R,3S)-3-Amino-cyclopentanol is a versatile synthetic intermediate with a primary role in pharmaceutical synthesis. This compound serves as a crucial building block for the development of various bioactive molecules. Its unique structure enables applications in medicinal chemistry and drug design, facilitating the exploration of novel therapeutic agents. -
Drug Intermediate
8-Methyl-4-oxo-N,N-dipropyl-4H-thieno[3,2-c]chromene-2-carboxamide serves as a critical drug intermediate in the synthesis of pyruvate kinase inhibitors. This compound is instrumental in the development of therapeutic agents targeting metabolic pathways, particularly in cancer research, where modulation of pyruvate kinase activity may influence tumor growth and survival. Its utility in synthetic biology allows for the exploration of novel treatments aimed at metabolic dysregulation. -
Drug Intermediate
7-Methoxy-8-(3-morpholin-4-ylpropoxy)-2,3-dihydroimidazo[1,2-c]quinazolin-5-amine serves as a key synthetic intermediate in pharmaceutical synthesis. Its unique structure enables specific modifications, making it integral in the development of compounds aimed at various therapeutic applications. This reagent is essential for researchers working on imidazoquinazoline derivatives and their biological activity within drug discovery frameworks. -
Drug Intermediate
8-Isoquinoline methanamine hydrochloride is a synthetic compound primarily utilized as a drug intermediate in pharmaceutical synthesis. This reagent is critical for the development of various bioactive molecules, enabling the production of novel therapeutic agents. Its utility in organic synthesis positions it as an essential component in the advancement of chemical research and drug discovery efforts.
